Special Issue "Antibiotic Resistance: From the Bench to Patients"
Deadline for manuscript submissions: closed (31 May 2020).
2. Department of Organic Chemistry, University of Barcelona, CIBER-BBN, Barcelona, Spain
Interests: antimicrobial peptides; solid-phase chemistry; combinatorial chemistry; drug delivery systems; peptide drug conjugates; orthogonal chemistry; drug discovery; biomaterials
Special Issues, Collections and Topics in MDPI journals
Special Issue in Molecules: Chemical Protein and Peptide Synthesis
Special Issue in Molecules: Combinatorial Synthesis
Special Issue in Marine Drugs: Selected Papers from the 14th International Symposium on Marine Natural Products
Special Issue in Molecules: Organic Synthesis on Solid Phase
Special Issue in Molecules: Peptide Therapeutics
Special Issue in Methods and Protocols: Feature Papers
Special Issue in Biomedicines: Peptides of Natural Origins as Leads for Drug Discovery: From Native Structures to Peptidomimetics, Peptide-Conjugates, and Peptide-Nanoparticles
Special Issue in Methods and Protocols: Feature Issue on the Development of Novel Cutting Edge Protocols
Special Issue in Microorganisms: New Cationic Antimicrobial Peptides
Special Issue in Methods and Protocols: Feature Papers 2021
Special Issue in Applied Sciences: Latest Advances on Synthesis, Purification, and Characterization of Peptides and Their Applications
Special Issue in Antibiotics: Antibiotics 2020 Young Investigator Award
Interests: epidemiology; clinical microbiology; resistance trends; UTIs, antimicrobial stewardship; knowledge-attitude-practice (KAP); novel antimicrobials; drug design; anaerobes
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Molecular Sciences: Anaerobic Bacteria and Their Resistance Mechanisms
Special Issue in Microorganisms: Anaerobic Bacteria and Their Resistance Mechanisms
Topics: Toll-Like Receptors and Their Potential Roles in Human Diseases
The emergence of multidrug-resistant (MDR) bacteria is a serious public health issue which requires global action of an intersectoral nature, involving physicians, pharmacists, patients, and the relevant stakeholders alike. As pharmaceutical companies are struggling to keep up with the increase in the resistance trends of various pathogens (most commonly termed “ESKAPE” bacteria), the conscious use of the existing antimicrobials (both qualitatively and quantitatively) is of utmost importance. General practitioners and community pharmacists usually represent the first-line of interaction with healthcare for most of the patients; therefore, they need to act as “gate keepers” while prescribing/dispensing antibiotics. The appropriateness of the healthcare professionals’ knowledge–attitude–practice (KAP) is critical for proper patient education and for attaining change in their attitudes. In addition, clinical microbiology laboratories have pivotal roles in reporting the epidemiological features of their region, in performing antimicrobial susceptibility testing, and in the detection of relevant resistance mechanisms, supplying important information to physicians in a clinically-relevant time frame, also, to support infection control measures to curb the spread of drug resistant bacteria.
The purpose of this Special Issue is to present novel results on the epidemiology of various MDR pathogens worldwide, to describe novel diagnostic and point-of-care (POCT) tests to aid proper antibiotic therapy, interventional studies to improve antimicrobial drug utilization, pharmacoepidemiological studies, and various studies reporting on the knowledge, attitude, and practice of healthcare professionals (nurses, doctors, pharmacists, etc.) and patients regarding antibiotics and antibiotic resistance.
Prof. Dr. Fernando Albericio
Dr. Márió Gajdács
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antibiotic resistance
- ESKAPE pathogens
- resistance detection
- point-of-care testing (POCT)
- clinical bacteriology
- infectious disease epidemiology
- drug utilization
- antimicrobial stewardship
- attitudes on antimicrobials
- knowledge on antimicrobials
- regulatory perspectives
- policy analysis
- primary care